These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3540826)

  • 21. Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against
    Everaert A; Coenye T
    Antimicrob Resist Infect Control; 2016; 5():44. PubMed ID: 27895902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Enzymologic aspect of piperacillin combinations].
    Labia R; Morand A; Verchere-Beaur C; Amrani R; Beklahia C
    Presse Med; 1986 Dec; 15(46):2303-8. PubMed ID: 2949272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains.
    Giwercman B; Lambert PA; Rosdahl VT; Shand GH; Høiby N
    J Antimicrob Chemother; 1990 Aug; 26(2):247-59. PubMed ID: 2170321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of Pseudomonas aeruginosa to piperacillin resistance mediated by beta-lactamase production.
    Bell SM; Pham JN; Lanzarone JY
    J Antimicrob Chemother; 1985 Jun; 15(6):665-70. PubMed ID: 3928573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftazidime therapy in patients with cystic fibrosis and multiply-drug-resistant pseudomonas.
    Blumer JL; Stern RC; Klinger JD; Yamashita TS; Meyers CM; Blum A; Reed MD
    Am J Med; 1985 Aug; 79(2A):37-46. PubMed ID: 3895917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
    Isles A; Maclusky I; Corey M; Gold R; Prober C; Fleming P; Levison H
    J Pediatr; 1984 Feb; 104(2):206-10. PubMed ID: 6420530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro expression of beta-lactam-induced response by clinical gram-negative bacteria with the potential for inducible beta-lactamase production.
    Bongaerts G; Roelofs-Willemse H
    Scand J Infect Dis; 1998; 30(6):579-83. PubMed ID: 10225386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates.
    Aronoff SC
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1636-9. PubMed ID: 2855296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of resistance by piperacillin during Pseudomonas aeruginosa endocarditis.
    Letendre ED; Mantha R; Turgeon PL
    J Antimicrob Chemother; 1988 Oct; 22(4):557-62. PubMed ID: 3144526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoelectric focusing of beta-lactamases in Mycobacterium fortuitum. Association of a single enzyme pattern with cefoxitin resistance.
    Wallace RJ; Nash DR; Udou T; Steingrube VA; Steele LC; Swenson JM; Silcox VA
    Am Rev Respir Dis; 1985 Nov; 132(5):1093-7. PubMed ID: 3877482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of inducible beta-lactamase in sputum--clinical studies on Pseudomonas respiratory infection].
    Nakahama C; Kurokawa Y; Ueda S; Soejima R; Yamada M; Araki H; Minami S; Watanabe Y; Yasuda T; Saikawa I
    Kansenshogaku Zasshi; 1989 Apr; 63(4):400-9. PubMed ID: 2506298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two selective media developed to isolate Pseudomonas cepacia from patients with cystic fibrosis.
    Black-Payne C; Lierl MB; Bocchini JA; Hilman BC; Rambin ED; Silberman R
    Diagn Microbiol Infect Dis; 1987 Apr; 6(4):277-82. PubMed ID: 3581734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis.
    Jenkins RE; Yaseen FS; Monshi MM; Whitaker P; Meng X; Farrell J; Hamlett J; Sanderson JP; El-Ghaiesh S; Peckham D; Pirmohamed M; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2013 Jun; 26(6):963-75. PubMed ID: 23668298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration of inducible beta-lactamase in gram-negative organisms.
    Dyas A; Dixon C
    J Antimicrob Chemother; 1984 Nov; 14(5):559-60. PubMed ID: 6334684
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of broad-spectrum parenteral antibiotics on "colonization resistance" of intestinal microflora of humans.
    Barza M; Giuliano M; Jacobus NV; Gorbach SL
    Antimicrob Agents Chemother; 1987 May; 31(5):723-7. PubMed ID: 3496848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic evaluation of piperacillin for acute pulmonary exacerbations in cystic fibrosis.
    Reed MD; Stern RC; Myers CM; Klinger JD; Yamashita TS; Blumer JL
    Pediatr Pulmonol; 1987; 3(2):101-9. PubMed ID: 3588053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia.
    Lewin C; Doherty C; Govan J
    Antimicrob Agents Chemother; 1993 Jan; 37(1):123-5. PubMed ID: 8431009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.
    LiPuma JJ; Dasen SE; Nielson DW; Stern RC; Stull TL
    Lancet; 1990 Nov; 336(8723):1094-6. PubMed ID: 1977981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.
    Gilligan PH; Gage PA; Bradshaw LM; Schidlow DV; DeCicco BT
    J Clin Microbiol; 1985 Jul; 22(1):5-8. PubMed ID: 4019742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients.
    Hardy KA; McGowan KL; Fisher MC; Schidlow DV
    J Pediatr; 1986 Jul; 109(1):51-4. PubMed ID: 3723240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.